Medulloblastoma, Childhood

Search with Google Search with Bing
Information
Disease name
Medulloblastoma, Childhood
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06193759 Active, not recruiting Phase 1 Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) June 4, 2024 December 29, 2033
NCT04528316 Completed N/A Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor August 6, 2020 April 30, 2021
NCT02238899 Completed Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma January 2011 December 2014
NCT04860934 Completed N/A Dual Task Training On Children With Ataxia After Medulloblastoma Resection March 15, 2021 November 30, 2021
NCT05406947 Not yet recruiting Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children January 30, 2023 December 31, 2030
NCT04185038 Recruiting Phase 1 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors December 11, 2019 May 2041
NCT05057702 Recruiting N/A Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma February 22, 2022 January 31, 2027
NCT05230758 Recruiting Phase 3 Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour July 1, 2022 June 30, 2027
NCT05298995 Recruiting Phase 1 GD2-CAR T Cells for Pediatric Brain Tumours November 9, 2023 November 2038
NCT03904862 Suspended Phase 1/Phase 2 Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery July 25, 2019 February 7, 2029
NCT02624388 Terminated Phase 2 Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) August 2016 September 2021
NCT04167618 Terminated Phase 1/Phase 2 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma September 30, 2021 August 11, 2022
NCT03288168 Unknown status Children's and Adolescents' Medulloblastoma Molecular Subgroups in China September 1, 2017 June 30, 2021
NCT04174820 Unknown status Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition November 12, 2020 November 1, 2022
NCT01697514 Withdrawn Phase 1 A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma July 2013 July 2016